Icecure Medical (ICCM) revenue and earnings history
Icecure Medical reported revenue of $3.38M for fiscal 2025 (year ended Dec 31, 2025), +2.7% on the year before, and net income of −$15.1M.
Over 6 years, from fiscal 2019 to fiscal 2025, revenue grew at a compound rate of +13.0% a year.
Revenue and net income, 7 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $3.38M+2.7% | −$15.1M | −$15.1M | −$14.6M | $36K | −$14.6M | $1.37M | — | — | $8.9M | $13K | 20-F |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Icecure Medical (ICCM) on OQRO.
Common questions
What was Icecure Medical's revenue in fiscal 2025?
$3.38M for the year ended Dec 31, 2025, as reported in its 20-F filed Mar 17, 2026. That is +2.7% on fiscal 2024 ($3.29M).
How fast has Icecure Medical's revenue grown?
From $1.63M in fiscal 2019 to $3.38M in fiscal 2025: a compound annual growth rate of +13.0% over 6 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Icecure Medical been profitable?
Where these figures come from
The SEC’s companyfacts data: every figure Icecure Medical tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
